OrbiMed Advisors »

Cybin shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Cybin (HELP) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $31M 3.8M 8.18

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Sinovac Biotech SHS
Edwards Lifesciences (EW)
Upstream Bio (UPB)
Intuitive Surgical Com New (ISRG)
Sionna Therapeutics (SION)
Mbx Biosciences (MBX)
Argenx Se Sponsored Adr (ARGX)
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Terns Pharmaceuticals (TERN)

View all positions for OrbiMed Advisors

Top funds holding Cybin

Point72 Asset Management
OrbiMed Advisors
VR Adviser
Deep Track Capital
Rosalind Advisors
Acorn Capital Advisors
Eventide Asset Management
Sphera Funds Management
DCF Advisers
Boxer Capital Management
Susquehanna International
Nan Fung Group Holdings
DAFNA Capital Management
Stonepine Capital Management
Knott David M Jr

View all funds holding Cybin